Yarbrough Capital, LLC Axsome Therapeutics, Inc. Transaction History
Yarbrough Capital, LLC
- $2.29 Billion
- Q1 2024
A detailed history of Yarbrough Capital, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 5,054 shares of AXSM stock, worth $398,912. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,054Holding current value
$398,912% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$355 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$295 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$252 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$186 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$103 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.38B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...